Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
NEUROLOGY 2005;65:785
© 2005 American Academy of Neurology

September 27 Highlight and Commentary

Effect of sildenafil (Viagra) on cerebral blood vessels

Sildenafil increases cerebrovascular reactivity

Diomedi et al. found a significant improvement of cerebrovascular reactivity 1 hour after 50 mg of sildenafil (Viagra). Effects on cerebral endothelial function could contribute to sildenafil-induced migraine.

see page 919

Effect of sildenafil (Viagra) on cerebral blood vessels

Commentary by Karen C. Johnston, MD, MSc

Sildenafil is a selective inhibitor of phosphodiesterase type 5 and is used for the treatment of male erectile dysfunction. It causes relaxation of vascular smooth muscle via a cyclic guanosine monophosphate (cGMP) second messenger that results in a vasodilatory effect in the corpus cavernosum. A dilatory effect on peripheral blood vessels has also been identified and vascular side effects primarily include facial flushing, nasal congestion, headache, and other minor symptoms. Blood pressure reduction, especially when sildenafil is used in conjunction with nitrates, has been recognized and therefore its use in association with nitrates is not recommended. Due to concerns regarding the risk of sildenafil in patients with cardiovascular disease, a consensus panel recommended a risk stratification and patient management process prior to initiation of therapy in patients with cardiovascular disease.1 Transient ischemia,2 stroke,2 and intracerebral hemorrhage3 have also been reported in association with use of sildenafil but causality remains unclear.

Early exploration of the relationship between sildenafil and cerebral blood flow has not demonstrated any substantial effect on flow. In a randomized, double-blind, placebo controlled trial of 28 men, Diomedi et al. again suggest that sildenafil does not affect cerebral blood flow velocity. However, using a breath holding index and transcranial Doppler to assess the endothelial response to hypercapnia, they demonstrated that a single 50 mg dose of sildenafil produces an improvement in cerebrovascular reserve. Though this may reduce the concern for the use of sildenafil in patients at risk for cerebrovascular disease, it may increase the concern in migraineurs as migraine is a recognized side effect. Further studies are necessary to evaluate subjects with known cardiovascular and cerebrovascular disease and with higher dosing regimens and repeated dosing. Such studies may help to inform decisions on the risk benefit ratio of using this therapy in specific patient populations.

see page 919

References

  1. DeBusk R, Drory Y, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular diseases: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86:175–181.[Medline]
  2. Morgan JC, Alhatou M, Oberlies J, Johnston K. Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology 2001;57:1730–1731.[Free Full Text]
  3. Buxton N, Flannery T, Wild D, Bassi S. Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage. Br J Neurosurg 2001;15:347–349.[Medline]

Related articles in Neurology:

Sildenafil increases cerebrovascular reactivity: A transcranial Doppler study
M. Diomedi, F. Sallustio, B. Rizzato, F. Ferrante, G. Leone, E. Spera, M. Scarfini, and G. Bernardi
Neurology 2005 65: 919-921. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS